Lovastatin

• Post Date:

  Jan 09,2014

• Expiry Date:

  Jul 08,2014

• Detailed Description:

  Cas No. :75330-75-5 Quantity: 500Kilograms
  Payment Method: T/T
  Lovastatin
  English Synonyms: )ethyl]-1-naphthalenylester;[1s-[1alpha(r*),3alpha,7beta,8beta(2s*,4s*),8abeta]]-2-methylbutanoicacid1,2,;1,2,6,7,8,8a-hexahydro-beta,delta-dihydroxy-2,6-dimethyl-8-(2-methyl-1-oxobuty;2-methyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-butanoicaci;3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2h-pyran-2-yl;3r,7s,8s,8ar)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[2r,4r)-tetrahydro-(1;4-hydroxy-6-oxo-2h-pyran-2-yl)ethyl)-1-naphthalenylester,(1s-(1-alpha-(r*),3;4-hydroxy-6-oxo-2h-pyran-2-yl]ethyl]-1-naphthalenyl(s)-2-methyl-butyrate
  
  CAS NO.: 75330-75-5
  Assay: 98%
  Molecular Formula: C24H36O5
  Molecular Weight:404.54
  Packing:25kg
  Appearance: White crystal
  Usage: Lovastatin is a member of the drug class of statins, used for lowering cholesterol (hypolipidemic agent) in those with hypercholesterolemia and so preventing cardiovascular disease.
  
  Contact Person:Mandy Wang
  ycmanagers02(AT)ycphar.com
  86-18062666917
  SKPYE:ycmanagers02

• CAS Registry Number:

  75330-75-5

• Synonyms:

  ;mevlor;msd803;oxy)-1-naphthaleneheptanoicaciddelta-lactone ;Lovastation;Lovastin;Lovalip;Mevinolin;8-[2-(4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2-methylbutanoate;(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate;(1S,3R,7S,8S)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate;Red Yeast Rice P.E;

• Molecular Formula:

  C₂₄H₃₆O₅

• Molecular Weight:

  404.5396

• Molecular Structure:

  

• Safety Description:

  S22:;
  S24/25:;
  

• Company:

  wuhan hezhong chemical manufacture co.,ltd     [ China ]        

• Contact:

  Mandy

• Tel:

  027-68886732

• Fax:

  027-88048077

• Email:

  ycmanagers02@ycphar.com